| P50 | author | Yangchao Chen | Q60312749 |
| | Ka Fai To | Q99551275 |
| | Nathalie Wong | Q114442539 |
| | Wing-Kit Yip | Q117282527 |
| | Ranxu Zhu | Q117282528 |
| | Vincent Wai-Sun Wong | Q38135899 |
| | Henry Lik-Yuen Chan | Q38135921 |
| | Joseph Jao-Yiu Sung | Q38135970 |
| | Paul Bo-San Lai | Q43682730 |
| | Alfred S. Cheng | Q44364620 |
| P2093 | author name string | Jun Yu | |
| | Daisy Pui-Fong Tsang | |
| | Enders Kai-On Ng | |
| | Jonathan Gabriel Sung | |
| | Raymond Wai-Ming Lung | |
| | Suki Shuk-Kei Lau | |
| P2860 | cites work | MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B | Q24564757 |
| | MicroRNA-210 regulates cancer cell proliferation through targeting fibroblast growth factor receptor-like 1 (FGFRL1) | Q24617676 |
| | MicroRNA expression, survival, and response to interferon in liver cancer | Q24647241 |
| | Hypoxia-inducible mir-210 regulates normoxic gene expression involved in tumor initiation. | Q24651016 |
| | Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model | Q24655262 |
| | Hepatitis B virus HBx protein sensitizes cells to apoptotic killing by tumor necrosis factor alpha | Q27485874 |
| | Hepatitis C Virus Proteins Modulate MicroRNA Expression and Chemosensitivity in Malignant Hepatocytes | Q27490901 |
| | MicroRNA 29c is down-regulated in nasopharyngeal carcinomas, up-regulating mRNAs encoding extracellular matrix proteins | Q27863380 |
| | Effects of microRNA-29 on apoptosis, tumorigenicity, and prognosis of hepatocellular carcinoma | Q28118779 |
| | Small RNAs analysis in CLL reveals a deregulation of miRNA expression and novel miRNA candidates of putative relevance in CLL pathogenesis | Q28256626 |
| | MiRNA-26b regulates the expression of cyclooxygenase-2 in desferrioxamine-treated CNE cells | Q28271329 |
| | MYC stimulates EZH2 expression by repression of its negative regulator miR-26a | Q28291303 |
| | Human embryonic stem cells and metastatic colorectal cancer cells shared the common endogenous human microRNA-26b | Q28292904 |
| | MiR-26a inhibits cell growth and tumorigenesis of nasopharyngeal carcinoma through repression of EZH2 | Q28302211 |
| | Characterisation of hepatitis B virus X protein mutants in tumour and non-tumour liver cells using laser capture microdissection. | Q30967003 |
| | MicroRNA-193b represses cell proliferation and regulates cyclin D1 in melanoma | Q33816470 |
| | Liver-enriched transcription factors regulate microRNA-122 that targets CUTL1 during liver development. | Q34138074 |
| | Negative regulation of the tumor suppressor p53 gene by microRNAs. | Q34142778 |
| | The hepatitis B virus X protein sensitizes HepG2 cells to UV light-induced DNA damage | Q34438821 |
| | Hepatitis B virus X protein and the estrogen receptor variant lacking exon 5 inhibit estrogen receptor signaling in hepatoma cells | Q34666783 |
| | Hepatitis B virus transactivator protein X interacts with the TATA-binding protein. | Q34673509 |
| | Epstein-Barr virus latent membrane protein 1 induces cellular MicroRNA miR-146a, a modulator of lymphocyte signaling pathways | Q34721581 |
| | Association of MicroRNA expression in hepatocellular carcinomas with hepatitis infection, cirrhosis, and patient survival. | Q34742406 |
| | MicroRNA-223 is commonly repressed in hepatocellular carcinoma and potentiates expression of Stathmin1. | Q34786558 |
| | Stepwise up-regulation of microRNA expression levels from replicating to reversible and irreversible growth arrest states in WI-38 human fibroblasts | Q34983424 |
| | Genotype C hepatitis B virus infection is associated with an increased risk of hepatocellular carcinoma. | Q35596851 |
| | Hepatitis B virus X antigen in the pathogenesis of chronic infections and the development of hepatocellular carcinoma | Q35764338 |
| | Hepatocellular carcinoma and hepatitis B virus | Q36467980 |
| | High viral load and hepatitis B virus subgenotype ce are associated with increased risk of hepatocellular carcinoma | Q45397941 |
| | The hepatitis B virus X protein functionally interacts with CREB-binding protein/p300 in the regulation of CREB-mediated transcription. | Q45409349 |
| | Hepatitis B virus X mutants, present in hepatocellular carcinoma tissue abrogate both the antiproliferative and transactivation effects of HBx. | Q45747173 |
| | HBx gene of hepatitis B virus induces liver cancer in transgenic mice | Q45852802 |
| | Lentivirus-mediated RNA interference targeting enhancer of zeste homolog 2 inhibits hepatocellular carcinoma growth through down-regulation of stathmin. | Q53544194 |
| | miR-29 miRNAs activate p53 by targeting p85 alpha and CDC42. | Q54780999 |
| | RNA interference targeting HBx suppresses tumor growth and enhances cisplatin chemosensitivity in human hepatocellular carcinoma | Q79764501 |
| | MicroRNA-193b regulates proliferation, migration and invasion in human hepatocellular carcinoma cells | Q84590881 |
| | Genotype-specific genomic markers associated with primary hepatomas, based on complete genomic sequencing of hepatitis B virus. | Q36498203 |
| | The hepatitis B virus HBx protein is a dual specificity cytoplasmic activator of Ras and nuclear activator of transcription factors | Q36684890 |
| | MicroRNA miR-146a and further oncogenesis-related cellular microRNAs are dysregulated in HTLV-1-transformed T lymphocytes | Q37067623 |
| | Oncogenic HPV infection interrupts the expression of tumor-suppressive miR-34a through viral oncoprotein E6 | Q37142068 |
| | MicroRNAs and cancer epigenetics. | Q37179121 |
| | NF-kappaB-YY1-miR-29 regulatory circuitry in skeletal myogenesis and rhabdomyosarcoma | Q37311506 |
| | Breast cancer metastasis suppressor 1 up-regulates miR-146, which suppresses breast cancer metastasis | Q37368106 |
| | Deregulated direct targets of the hepatitis B virus (HBV) protein, HBx, identified through chromatin immunoprecipitation and expression microarray profiling | Q37372165 |
| | Modulation of LMP2A expression by a newly identified Epstein-Barr virus-encoded microRNA miR-BART22 | Q37399274 |
| | Epigenetic regulation of signaling pathways in cancer: role of the histone methyltransferase EZH2. | Q37822876 |
| | Combinatorial analysis of transcription factor partners reveals recruitment of c-MYC to estrogen receptor-alpha responsive promoters. | Q38316206 |
| | EZH2-mediated concordant repression of Wnt antagonists promotes β-catenin-dependent hepatocarcinogenesis. | Q39554903 |
| | Lethal-7 is down-regulated by the hepatitis B virus x protein and targets signal transducer and activator of transcription 3. | Q39706915 |
| | miR-193b is an epigenetically regulated putative tumor suppressor in prostate cancer. | Q39752124 |
| | Hepatitis B viral X protein alters the biological features and expressions of DNA repair enzymes in LO2 cells | Q39766005 |
| | Downregulation of miR-193b contributes to enhance urokinase-type plasminogen activator (uPA) expression and tumor progression and invasion in human breast cancer | Q39809297 |
| | Subcellular mislocalization of mutant hepatitis B X proteins contributes to modulation of STAT/SOCS signaling in hepatocellular carcinoma. | Q39868194 |
| | Differential microRNA expression between hepatitis B and hepatitis C leading disease progression to hepatocellular carcinoma | Q39890346 |
| | MicroRNA-101, down-regulated in hepatocellular carcinoma, promotes apoptosis and suppresses tumorigenicity | Q39893180 |
| | COOH-terminal truncated HBV X protein plays key role in hepatocarcinogenesis | Q39951374 |
| | Diagnostic and prognostic implications of microRNAs in human hepatocellular carcinoma | Q39958103 |
| | COX-2 mediates hepatitis B virus X protein abrogation of p53-induced apoptosis | Q39965123 |
| | X protein of hepatitis B virus functions as a transcriptional corepressor on the human telomerase promoter | Q40121980 |
| | Aberrant epigenetic modifications in hepatocarcinogenesis induced by hepatitis B virus X protein | Q40149729 |
| | Expression of HBx and COX-2 in chronic hepatitis B, cirrhosis and hepatocellular carcinoma: implication of HBx in upregulation of COX-2. | Q40541428 |
| | X protein of hepatitis B virus inhibits Fas-mediated apoptosis and is associated with up-regulation of the SAPK/JNK pathway | Q40839488 |
| | A long-term hepatitis B viremia model generated by transplanting nontumorigenic immortalized human hepatocytes in Rag-2-deficient mice | Q40909623 |
| | MiR-222 overexpression confers cell migratory advantages in hepatocellular carcinoma through enhancing AKT signaling. | Q41412869 |
| | Loss of mir-146a function in hormone-refractory prostate cancer | Q42055882 |
| | Biological impact of natural COOH-terminal deletions of hepatitis B virus X protein in hepatocellular carcinoma tissues. | Q42663074 |
| | Correlation of tissue-specific methylation with gene inactivity in hepatitis B virus transgenic mice | Q43984536 |
| | Association of human APOBEC3 cytidine deaminases with the generation of hepatitis virus B x antigen mutants and hepatocellular carcinoma | Q44956160 |
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | microRNA | Q310899 |
| | hepatocellular carcinoma | Q1148337 |
| P304 | page(s) | e22888 | |
| P577 | publication date | 2011-08-04 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Carboxyl-terminal truncated HBx regulates a distinct microRNA transcription program in hepatocellular carcinoma development | |
| P478 | volume | 6 | |